Key Drivers
- High gross margin
- Negative cash flow
- Very high leverage
AIAI Summary
ESTA has shifted from a growth-at-all-costs developer to a near-term profit-recovery story—recent positive adjusted EBITDA and strong U.S. margin mix mean the investment now hinges on management converting EBITDA into sustained free cash flow to materially de-risk the heavy ~$250M noncurrent debt. Monitor quarterly FCF cadence, inventory/receivables conversion, and any debt-refinancing milestones as the single factors that will validate upside or trigger sharp valuation downside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High gross margin
- •Negative cash flow
- •Very high leverage
ESTA combines strong gross margins and short-term liquidity with sustained operating losses, negative free cash flow and extreme leverage that create material solvency and valuation risk despite rich market pricing.
Price Behavior
Key Price Behavior Insights:
- •Clear downtrend
- •Support cluster
- •Oversold momentum
ESTA has dropped ~17.6% over the last month into a clear downtrend, trading near $62–$64 support with resistance at ~$70–$71 and $76–$80, so a decisive break below $62 would imply further losses while a sustained move above ~$71–$76 would signal trend reversal.
~17.6% decline over the last month indicating steep recent selloff
Sentiment & News
Key News Insights:
- •Narrowed losses
- •CFO transition
- •Moderate buy consensus
Establishment Labs beat Q4 expectations with a sharply reduced loss and announced a CFO-to-SVP transition alongside a new CFO hire, signaling operational improvement and governance change amid cautiously optimistic analyst sentiment.
The earnings beat and executive reshuffle should support short-term investor confidence, while execution and integration of the new finance leadership will determine sustained upside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings